BNET Industries

Market Cap:$321.9K
Last Fiscal Year Sales:$449.0K
  • Public
  • US
Dow Jones Description

Endovasc's licenses and patents describe technological advancements related to liposomes, stent coatings, and biodegradable/resorbable prostheses (stents) for the treatment of vascular dysfunction and heart disease. It also holds licenses and patents for the treatment of vascular dysfunction related to heart disease.

Chief Operations Officer, Director
Dwight Cantrell
Number of Employees 4
Contact Information

550 Club Dr Ste 345

Montgomery, Texas 77316

endovasc.com

(936) 582-5920

NAICS Code Corporate, Subsidiary, and Regional Managing Offices: 551114

News & Analysis

endovasc inc. and samsonite corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Dwight Cantrell Chief Operations Officer, Director
David Zazoff Manager, Investor Relations
Alan B Lumsden
Caroline E Fife
Craig J Hartley
Fred Lowrey Consultant, Clinical Research
Nathan Blumberg
Robert B Rutherford Scientific Advisor for Endovasc's Phase III Lipros
Yong-Jian Geng
E Michael Prater Director

Board of Directors

Name (plus bio) Position
Barbara J. Richardson Board of Directors

Organization Position Status
Endovasc, Inc. Chief Operations Officer, Director Current
Endovasc, Inc. Treasurer Former

Organization Position Status
Endovasc, Inc. Manager, Investor Relations Current

Dr. Lumsden is Medical Director of the Methodist DeBakey Heart & Vascular Center at The Methodist Hospital in Houston, Texas. Prior to this, he was full Professor and Chair, Department of Cardiovascular Surgery, The Methodist Hospital. Previously he was Professor and Chief of Vascular Surgery and Endovascular Therapy in The Michael E. DeBakey Department of Surgery at Baylor College of Medicine in Houston, Texas. He was also the Chief of Vascular Surgery, Department of Surgery of the Emory School of Medicine in Atlanta. Dr. Lumsden has received many grants to perform research in the areas of subcutaneous saphenous vein harvest, effects of locally infused nonanticoagulant heparin on venous neointimal hyperplasia, and thrombosis and vascular lesion formation. In 1996, Dr. Lumsden was inducted into the membership committee of the Society for Clinical Vascular Surgery. He is also a board member for the Society for Clinical Vascular Surgery, Association of VA Surgeons as well as the International Society for Endovascular Surgery. He received both his bachelor of medical sciences and bachelor of medicine and surgery from the University of Edinburgh. He interned at the Royal Infirmary of Edinburgh, where he was also a lecturer in the departments of Pathology and Clinical Surgery. Dr. Lumsden has published and presented articles on his research more than 200 times and been an invited speaker both in the US. and abroad.

Organization Position Status
Methodist Hospital Medical Director Current
Emory University Associate Professor Current
Endovasc, Inc. Current
Endovascular Forum Co-Chair, Medical Advisory Board Current
Northpoint Domain, Inc. Co-Chair, Vascular Domain, The Methodist Hospital, Houston Current
Society for Clinical Vascular Surgery Board Member Current
Baylor College of Medicine Chief of Vascular Surgery and Endovascular Therapy Former
Emory School of Medicine Chief of Vascular Surgery Former
Emory University School of Medicine Chief of General Vascular Surgery Former
Pathology Inc. Lecturer Former
Baylor College of Medicine Prof Former

Organization Position Status
Intellicure President Current
The Aerospace Corporation Associate Professor Current
Endovasc, Inc. Current
The Aerospace Corporation Director Current
American Academy of Wound Management Board of Directors Current
Divers Alert Network, Inc. Board of Directors Former
Texas A&M University BS In Medical Science Former

Organization Position Status
Beverly Hills Weight Loss & Wellness, Inc. Professor of Medicine Current
Baylor College of Medicine Professor of Cardiovascular Sciences Current
Endovasc, Inc. Current
Endothelix Inc Board of Directors Current

Organization Position Status
Endovasc, Inc. Consultant, Clinical Research Current

Organization Position Status
Endovasc, Inc. Current
St. Louis University School of Medicine M.D. Former

Organization Position Status
Endovasc, Inc. Scientific Advisor for Endovasc's Phase III Lipros Current

Organization Position Status
Endovasc, Inc. Current
University of Texas Health Science Center director of the Center for Cardiovascular Biology and Atherosclerosis Research Former
American Heart Association, Inc. Former

Organization Position Status
Endovasc, Inc. Board of Directors Current

Organization Position Status
Endovasc, Inc. Director Current
advertisement
     EVSC $0.00 0.00 (0.00% )
Average Volume 78,767
Shares Outstanding 160.98M
Market Cap 241.5K
Year High 0.007
Year Low 0.0002
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
advertisement